Nordec Laboratories Private Limited
About Nordec Laboratories Private Limited
Data last updated:
Nordec Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC362154. Its GSTIN is 07AAGCN8930K1Z1 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kishan Mohan and Nidhi Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 5 – 22 Ground Floor Gate No. 1 Block S Badli Industrial Area Phase I, Delhi, India – 110042.
Company details
Contact details
Nordec Laboratories Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 5 – 22 Ground Floor Gate No. 1 Block S Badli Industrial Area Phase I, Delhi, India – 110042
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nordec Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nordec Laboratories is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Nordec Laboratories Private Limited, buy the company report.
Financials of Nordec Laboratories Private Limited
FY 2025 filings availableNordec Laboratories Private Limited reported revenue of ₹4,628 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 96% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nordec Laboratories Private Limited, buy the company report.
Board of directors of Nordec Laboratories Private Limited
Nordec Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishan Mohan | Director | 20 Feb 2020 | 6 Years 8 Months | Current |
| Nidhi Aggarwal Also directs: Neoagis Estates LLP | Director | 20 Feb 2020 | 6 Years 8 Months | Current |
Auditor
Nordec Laboratories Private Limited is audited by AGARWAL PREETI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL PREETI & ASSOCIATES | FY 2023 | 031194N |
Shareholding
The shareholding of Nordec Laboratories Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Nordec Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nordec Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nordec Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nordec Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCN8930K1Z1 | Delhi | Active | 18 Mar 2020 |
To see the full GST registrations and return filing status of Nordec Laboratories Private Limited, buy the company report.
Recent activity
Nordec Laboratories Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Vijay Kumar Aggarwal ceased to be Director on 16 Mar 2024.
Frequently asked questions
Nordec Laboratories is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 February 2020 (6+ years old) and is registered under CIN U24304DL2020PTC362154.
Nordec Laboratories has 2 current directors:
- Kishan Mohan - Director
- Nidhi Aggarwal - Director
The latest financial statements of Nordec Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Nordec Laboratories is 07AAGCN8930K1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Nordec Laboratories is U24304DL2020PTC362154. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nordec Laboratories was incorporated on 20 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Vijay Kumar Aggarwal ceased to be Director on 16 Mar 2024. Kishan Mohan was appointed as Director on 20 Feb 2020. Nidhi Aggarwal was appointed as Director on 20 Feb 2020. Nordec Laboratories has 4 board changes on record in total.
The registered office of Nordec Laboratories is at Plot No. 5 – 22 Ground Floor Gate No. 1 Block S Badli Industrial Area Phase I, Delhi, India – 110042.
Nordec Laboratories operates in the pharma industry, in the drug formulation and development segment.
Nordec Laboratories can be reached at its registered office: Plot No. 5 – 22 Ground Floor Gate No. 1 Block S Badli Industrial Area Phase I, Delhi, India – 110042.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
